Reuters: Lilly drug reduces stent clot risks, study finds

[NaDiNe]

Lilly drug reduces stent clot risks, study finds
      

CHICAGO (Reuters) - Patients who got Eli Lilly and Co's anti-clotting drug prasugrel after a coronary stent procedure had fewer stent-related clots than those on standard drug therapy, an analysis released on Saturday found.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login